Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 12, 2009, Pages 1519-1523

  De Lourdes Bastos, M ^a,b   Osterbauer, B ^c   Mesquita, D L ^b   Carrera, C A ^b   Albuquerque, M J ^b   Silva, L ^b   Pereira, D N ^b   Riley, L ^c   Carvalho, E M ^b,d  

^a Octavio Mangabeira Hospital   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

HTLV 1; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LATENT PERIOD; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK; TUBERCULOSIS;

EID: 74949138750     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Edlich R F, Arnette J A, Williams F M. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-1). J Emerg Med 2000; 18: 109-119.
2. Dourado I, Alcantara L C, Barreto M L, Teixeira M G, Galvao-Castro B. HTLV-1 in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 2003; 34: 527-531.
3. Galvao-Castro B, Lourdes L, Rodrigues L G M. Distribution of human T-lymphotropic virus type I among blood donors: a nation-wide Brazilian study. Transfusion 1997; 37: 242-243.
4. Lemos A C L, Matos E D, Pedral-Sampaio D B, Netto E M. Risk of tuberculosis among household contacts in Salvador, Bahia, Brazil. Braz J Infect Dis 2004; 8: 424-430.
5. Marinho J, Galvao-Castro B, Rodrigues L C, Barreto M L. Increased risk of tuberculosis with human T lymphotropic virus I infection: a case-control study. J Acquir Immune Defic Syndr 2005; 40: 625-628.
6. Kaplan J E, Camera T, Hanne A. Low prevalence of human T lymphotropic virus type 1 among patients with tuberculosis in Senegal. J Acquir Immune Defic Syndr 1994; 7: 418-420.
7. Murphy E L, Glynn A S, Fridey J, et al. Increased prevalence of infectious diseases and other adverse outcome in human T lymphotropic virus type I and II -infected blood donors. Epidemiology Donor Study (REDS) Study Group. J Infect Dis 1997; 176: 1468-1475.
8. Verdonck K, Gonzalez E, Henostreza G, et al. HTLV-1 infection is frequent among out patients with pulmonary tuberculosis in Northern Lima, Peru. Int J Tuberc Lung Dis 2007; 11: 1066-1072.
9. Verdonck K, Gonzalez E, Schrooten W, Vanhan G, Gotuzzo E. HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1 infected patients in Peru. Epidemiol Infect 2007; 136: 1076-1083.
10. Gotuzzo E.Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999; 60: 146-149.
11. Brites C, Weyll M, Pedroso C, Badaro R. Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/ HTLV-1) infection in Bahia, Brazil. AIDS 2002; 16: 1292-1293.
12. Porto M A, Muniz A, Oliveira J Jr, Carvalho E M. Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis. Rev Soc Bras Med Trop 2002; 35: 641-649.
13. Porto A F, Neva F A, Bittencourt H, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Par Immunol 2001; 23: 503-507.
14. Bonecini-Almeida M G, Chitale S, Boutsikakis I, et al. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. J Immunol 1998; 160: 4490-4499.
15. Tan J S, Canaday D H, Boom W H, Balaji K N, Schwander S K, Rich E A. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8 + cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol 1997; 159: 290-297.
16. Carvalho E M, Bacellar O, Porto A F, Braga S, Galvao-Castro B, Neva F. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001; 27: 1-6.
17. Santos S B, Porto A F, Muniz A L, et al. Modulation of T-cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1. Neuroimmunomodulation 2006; 13: 145-151.
18. Murai K.Tachibana N, Shioiri S, et al. Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-1 carriers. J Acquir Immune Defic Syndr 1990; 3: 1006-1009.
19. Suzuki M, Dezzutti C S, Okayama A, et al. Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individuals. Clin Diagn Lab Immunol 1999:713-717.
20. Mascarenhas R E, Brodskyn C, Barbosa G, et al. Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens. Clin Vaccine Immunol 2006; 13: 547-552.
21. Pedral-Sampaio D B, Martins Netto E, Pedrosa C, Brites C, Duarte M, Harrington W Jr. Co-infection of tuberculosis and HIV/HTLV retroviruses. Frequency and prognosis among patients admitted in a Brazilian hospital. Braz J Infect Dis 1997; 1: 31-35.